探讨泌尿科医师如何对接受内镜前列腺剜除术 (EEP) 的患者进行前列腺癌 (PCa) 筛查和治疗。EEP 专家团队通过互动过程共同制定调查问题。该调查于2024年1月开始，2024年2月结束。102名泌尿科医生回应，显示大多数使用PSA和直肠指检进行筛查，PSA高和DRE异常提示前列腺MRI。 75% 进行 EEP 前活检。对于偶发的低级别前列腺癌，首选主动监测。对于中度前列腺癌，大多数使用 PSA 和 MRI 进行检查，如果 EEP 后活检呈阴性，通常会选择主动监测。对于异常的术后 PSA 阈值尚未达成共识。虽然泌尿科医师了解 EEP 候选者中的 PCa 管理，但未来的工作应集中于开发最佳的 EEP 术后筛查方案。© 2024。作者，获得 Springer Nature 独家许可有限的。

To explore how urologists manage prostate cancer (PCa) screening and treatment in patients undergoing endoscopic enucleation of the prostate (EEP).A team of experts in EEP collaboratively formulated the survey questions through an interactive process. The survey opened in January 2024 and closed in February 2024.102 urologists responded, revealing that most use PSA and digital rectal examination for screening, with high PSA and abnormal DRE prompting prostate MRI. 75% perform pre-EEP biopsies. For incidental low-grade PCa, active surveillance is preferred. For intermediate-grade PCa, most use PSA and MRI for workup, often choosing active surveillance if post-EEP biopsies are negative. There's no consensus on abnormal post-operative PSA thresholds.While urologists are aware of PCa management in EEP candidates, future work should focus on developing optimal post-EEP screening protocols.© 2024. The Author(s), under exclusive licence to Springer Nature Limited.